Overview
1
-
Novo Holdings is the controlling shareholder of Novo Nordisk and a life science investment company. The firm manages Novo Nordisk's endowment and invests in life science companies globally. Novo Holdings focuses on diabetes care, obesity, rare diseases, and other therapeutic areas through both venture capital and growth investments.
Stages
4
Sectors
5
Geographic focus
1
Portfolio companies
1
Companies from this investor’s TAAFT profile, ranked by latest known raise. Round details come from our company catalog.
- Companies
- 1
- Latest raises tracked
- $300M
- With round data
- 1
- Stages seen
- Debt Financing
-
Debt Financing Closed 16 rounds AI-native
- Valuation
- $12.69B
- Employees
- 3.8k
